Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis, Chronic Progressive

Explore clinical trials studying Multiple Sclerosis, Chronic Progressive. Study availability and eligibility vary by location and protocol.

177 public trials 29 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis, Chronic Progressive trial results

Completed

Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)

NCT01665144

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Berkeley, California, United States
  • Novartis Investigative Site Los Angeles, California, United States
  • Novartis Investigative Site Oceanside, California, United States
View all 290 locations
View Trial Details
Completed

Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS) or Primary Progressive Multiple Sclerosis (PPMS)

NCT02688985

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +11 more
Locations
  • Stanford University Palo Alto, California, United States
  • University of California at San Francisco San Francisco, California, United States
  • University Of Colorado Aurora, Colorado, United States
  • Yale University School of Medicine ; Pulmonary & Critical Care New Haven, Connecticut, United States
View all 17 locations
View Trial Details
Completed

Long Term Special Drug Use-results Surveillance for Mayzent in SPMS Patients

NCT04593927

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Novartis Investigative Site Anjo, Aichi-ken, Japan
  • Novartis Investigative Site Hekinan, Aichi-ken, Japan
  • Novartis Investigative Site Ichinomiya, Aichi-ken, Japan
  • Novartis Investigative Site Kariya, Aichi-ken, Japan
View all 174 locations
View Trial Details
Completed

A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis

NCT01194570

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Phoenix Neurological Associates Ltd Phoenix, Arizona, United States
  • Barrow Neurology Clinic Phoenix, Arizona, United States
  • Mayo Clinic- Scottsdale Scottsdale, Arizona, United States
  • Arizona Neuroscience Research LLC Phoenix, Arkansas, United States
View all 184 locations
View Trial Details
Completed

A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple Sclerosis

NCT03737812

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • St. Josephs Hospital and Med Center /ID# 202809 Phoenix, Arizona, United States
  • Sutter East Bay Medical Foundation-Jordon Research and Education Dev. Inst. /ID# 202448 Berkeley, California, United States
  • The Research Center of Southern California /ID# 202802 Carlsbad, California, United States
  • Vladimir Royter MD /ID# 202483 Hanford, California, United States
View all 37 locations
View Trial Details
Completed

Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS

NCT03799718

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +9 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Stanford University School of Medicine Redwood City, California, United States
  • The Mount Sinai Hospital New York, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details

Related conditions